BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Dec. 14, 2005
View Archived Issues
BioAlliance Pharma Completes Initial Public Offering For EUR30M
PARIS - BioAlliance Pharma SA completed its initial public offering on Eurolist Compartment C of the Euronext stock exchange in Paris, raising gross proceeds of some €30 million (US$35.9 million). (BioWorld International)
Read More
Domantis' Valuation Higher For £17M Third Financing
Read More
Dutch Team Finds Aspects Of Cell Cycle Checkpoints
Read More
Zealand Pharma Learning Lessons From Pulled IPO
Read More
Group Of GMO Crop Raiders Acquitted By French Court
Read More
Cellartis Brings In EUR 8M For Embryonic Stem Cell Work
Read More
Alizyme Reports Positive Data For Cetilistat, Plans Phase III
Read More
Other News To Note
Read More